Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Cineworld Falls On Warner Streaming Plans

Fri, 04th Dec 2020 10:33

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

BP, up 3.3%. The oil major was the best performing FTSE 100 stock after members of the OPEC+ cartel struck a deal to increase production over the coming months, but by less than anticipated in their previous accord.

----------

SSE, up 3.0%. The Perth, Scotland-based utility is selling a 10% stake in the UK Dogger Bank A and B project to Italian oil major Eni for GBP202.5 million. Eni will buy another 10% stake from Norway's Equinor to have 20% alongside SSE's 40% and Equinor's 40%.

----------

FTSE 100 - LOSERS

----------

Rolls-Royce, down 3.5%. The jet engine maker was the worst-performing blue chip stock, giving back some of this week's bumper gains. It had risen 16% on Thursday as positive vaccine developments boosted the prospects of global travel. The aerospace stock remains up 54% in the past month, though down 46% in the past year.

----------

FTSE 250 - WINNERS

----------

Micro Focus International, up 10%. The software firm was on Thursday touted by Amazon Web Services as one of the businesses that can help companies migrate data to the cloud. AWS noted Micro's deployment environment software which it provided to Kmart Australia.

----------

Premier Oil, up 6.7%. Like BP, the mid-cap oil company's shares rose following Thursday's OPEC+ meeting.

----------

FTSE 250 - LOSERS

----------

Cineworld Group, down 11%. AT&T subsidiary Warner Bros will release its entire 2021 slate of movies on HBO Max streaming and in theatres simultaneously, including "The Matrix 4" and Denis Villeneuve's "Dune" remake, the studio announced in a landmark response to the pandemic Thursday. The "hybrid model" will see films available on HBO Max streaming in the US for one month from the date of their theatrical release.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

N4 Pharma, up 52%. The Chellaston, England-based pharmaceutical company made further gains after it announced on Thursday that cancer drug Nuvec can be freeze dried and stored for 14 day without a significant drop in performance. N4 Pharma said Nuvec formulations which had been freeze dried and then stored for 14 days, either at room temperature or at four degrees celsius, showed no significant drop in in vitro transfection capability following its reconstitution.

----------

Hunters Property, up 44%. The Yorkshire-based estate agent confirmed it received a preliminary approach from Property Franchise Group over a potential takeover offer. Property Franchise shares were down 5.5%.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Petro Matad, down 8.7%. The oil firm said a meeting on the awarding of the Block XX exploitation licence in Mongolia has been postponed due to lockdown measures.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
24 Mar 2020 15:49

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
25 Feb 2020 11:42

N4 Pharma Annual Loss Narrows Amid Work To Improve Nuvec System

N4 Pharma Annual Loss Narrows Amid Work To Improve Nuvec System

Read more
25 Feb 2020 08:49

N4 Pharma narrows loss as it continues development work

(Sharecast News) - Specialist pharmaceutical company N4 Pharma reported a smaller operating loss for 2019 on Tuesday, at ?0.95m, compared to ?1.42m in the prior year.

Read more
11 Feb 2020 14:19

N4 Pharma shares rise on partnership with Nanomerics

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has signed a 14-month research collaboration with Nanomerics to produce and test two candidate formulations using its 'Nuvec' delivery system, it announced on Tuesday.

Read more
11 Feb 2020 11:37

N4 Pharma Signs Research Collaboration Agreement With Nanomerics

N4 Pharma Signs Research Collaboration Agreement With Nanomerics

Read more
18 Sep 2019 12:04

N4 Pharma Interim Loss Widens After Non-Repeat Of Grant, Disposal Gain

(Alliance News) - N4 Pharma PLC on Wednesday said its loss widened slightly in the first half of the year, owing to grant income and a gain on an investment sale the year before which did not in a

Read more
20 Aug 2019 11:49

N4 Pharma Repeats Study And Finds Nuvec Successful At "Certain Doses"

(Alliance News) - N4 Pharma PLC on Tuesday said it has repeated the in-vivo study of Nuvec and shown it does work "when using multiple injections at certain doses".Shares in N4 at

Read more
19 Jun 2019 13:38

N4 Pharma To Start Experiments On Nuvec; Results Due In Two Months

(Alliance News) - N4 Pharma PLC on Wednesday said it will begin experiments on its Nuvec system on Friday this week with results due in around two months.Shares in N4 were up 20% at 4.30 in

Read more
12 Jun 2019 16:04

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 13 JuneTescoWM Morrison SupermarketsSirius MineralsJust Jack 14 Evans 17 18

Read more
21 May 2019 13:25

N4 Pharma Appoints John Chiplin as Non-Executive Chairman

LONDON (Alliance News) - N4 Pharma PLC on Tuesday said it appointed John Chiplin as non-executive chair of the company with immediate effect.Furthermore, the pharmaceutical firm appointed a

Read more
14 May 2019 12:09

N4 Pharma Loss Narrowed By Cost; Will Explore Assets Outside Nuvec

LONDON (Alliance News) - N4 Pharma PLC on Tuesday reported a narrowed loss for 2018 on lower costs and said it is exploring new opportunities while continuing work on core Nuvec drug delivery in -

Read more
15 Apr 2019 15:33

N4 Pharma reassures shareholders over future of 'Nuvec'

(Sharecast News) - Specialist pharmaceutical company N4 Pharma updated the market on the development of 'Nuvec' on Monday, following the disclosure of inconsistencies in the efficacy of Nuvec between various in vitro and in vivo studies.

Read more
15 Apr 2019 15:20

N4 Pharma Finds Issues With In Vivo Nuvec Testing And Plans Repeat

LONDON (Alliance News) - N4 Pharma PLC on Monday said it has become aware of a number of issues with the in vivo studies of its Nuvec delivery system.On Tuesday last week, N4 announced of a

Read more
9 Apr 2019 11:27

N4 Pharma Shares Sink As Nuvec Fails To Produce Response In-Vivo

LONDON (Alliance News) - N4 Pharma PLC on Tuesday said early in-vivo tests of its Nuvec delivery system did not match positive results from in-vitro tests, causing shares to slump.Shares in

Read more
8 Feb 2019 13:18

N4 Pharma Raises GBP1.1 Million In Share Placing To Fund Nuvec System (ALLISS)

LONDON (Alliance News) - N4 Pharma PLC on Firday said it raised GBP1.1 million in a placing of 10.5 million shares at 10 pence each.N4 Pharma shares were trading down 18% at 10.10p each on

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.